• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿生酮饮食疗法:疗效和耐受性。

Ketogenic Diet Therapy in Infants: Efficacy and Tolerability.

机构信息

Child and Adolescent Neurology and Epilepsy, Mayo Clinic, Rochester, Minnesota.

Mayo Clinic, Rochester, Minnesota.

出版信息

Pediatr Neurol. 2018 May;82:13-18. doi: 10.1016/j.pediatrneurol.2017.10.018. Epub 2018 Jan 31.

DOI:10.1016/j.pediatrneurol.2017.10.018
PMID:29610033
Abstract

PURPOSE

This study evaluated tolerability and efficacy of the ketogenic diet in infants less than 12 months of age.

METHODS

Infants less than 12 months of age, commencing the ketogenic diet between September 2007 and July 2016 were identified. Records were reviewed for epilepsy details, diet initiation details, efficacy and tolerability.

RESULTS

Twenty-seven infants commenced the ketogenic diet (56% male, median age seven months). Median age at seizure onset was 1.9 months and 92% had daily seizures. An epilepsy syndrome was noted in 19 (West-11, epilepsy in infancy with migrating focal seizures-5, early myoclonic encephalopathy-1, Ohtahara-1, Dravet-1). Infants were on a median of two and had failed a median of one medications for lack of efficacy. All initiated a traditional ketogenic diet at full calories without fasting, and all but one started the diet in hospital. Significant hypoglycemia during initiation was seen in two - both had emesis +/- decreased oral intake. Eighty-eight percent developed urinary ketosis by 48 hours and all were successfully discharged on the diet (median ratio 3:1). Of those continuing dietary therapy, responder rates at one, six and 12 months were 68%, 82% and 91%, with 20%, 29% and 27% achieving seizure freedom. By 12 months, two stopped the diet for serious adverse effects, five discontinued for lack of efficacy, six were lost to follow-up and two died of unrelated causes.

CONCLUSIONS

The ketogenic diet is an effective and well-tolerated treatment for infants with intractable epilepsy. In-hospital initiation is strongly recommended due to risk of hypoglycemia with emesis or reduced intake.

摘要

目的

本研究评估了生酮饮食在 12 个月以下婴儿中的耐受性和疗效。

方法

确定了 2007 年 9 月至 2016 年 7 月期间开始生酮饮食的 12 个月以下婴儿。回顾了记录以获取癫痫详细信息、饮食起始详细信息、疗效和耐受性。

结果

27 名婴儿开始生酮饮食(56%为男性,中位数年龄为 7 个月)。发病中位年龄为 1.9 个月,92%的婴儿每天都有癫痫发作。19 名婴儿患有癫痫综合征(West-11、婴儿期癫痫伴移行性局灶性发作-5、早发性肌阵挛性脑病-1、Ohtahara-1、Dravet-1)。中位数使用了两种药物,因疗效不佳而中位数使用了一种药物。所有婴儿均按全热量起始传统生酮饮食,无需禁食,且除 1 例外均在医院起始饮食。2 例婴儿在起始时出现严重低血糖,均伴有呕吐 +/-减少口服摄入量。88%的婴儿在 48 小时内出现尿酮症,所有婴儿均成功出院(中位数比例为 3:1)。继续进行饮食治疗的婴儿中,1、6、12 个月时的应答率分别为 68%、82%和 91%,20%、29%和 27%的婴儿达到无癫痫发作。12 个月时,2 名婴儿因严重不良反应停止饮食,5 名婴儿因疗效不佳停止饮食,6 名婴儿失访,2 名婴儿因其他原因死亡。

结论

生酮饮食是治疗难治性癫痫婴儿的有效且耐受性良好的治疗方法。由于呕吐或摄入量减少可能导致低血糖,强烈建议在医院起始饮食。

相似文献

1
Ketogenic Diet Therapy in Infants: Efficacy and Tolerability.婴儿生酮饮食疗法:疗效和耐受性。
Pediatr Neurol. 2018 May;82:13-18. doi: 10.1016/j.pediatrneurol.2017.10.018. Epub 2018 Jan 31.
2
The Ketogenic and Modified Atkins Diet Therapy for Children With Refractory Epilepsy of Genetic Etiology.生酮饮食和改良阿特金斯饮食疗法治疗遗传病因所致儿童难治性癫痫。
Pediatr Neurol. 2019 May;94:32-37. doi: 10.1016/j.pediatrneurol.2018.12.012. Epub 2018 Dec 29.
3
Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome.前瞻性研究生酮饮食对 20 例 Dravet 综合征患者的疗效。
Seizure. 2018 Aug;60:144-148. doi: 10.1016/j.seizure.2018.06.023. Epub 2018 Jun 30.
4
Initiating the ketogenic diet in infants with treatment refractory epilepsy while maintaining a breast milk diet.在婴儿治疗抵抗性癫痫发作时启动生酮饮食,同时保持母乳喂养。
Seizure. 2019 Jul;69:41-43. doi: 10.1016/j.seizure.2019.03.017. Epub 2019 Mar 26.
5
Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia.生酮饮食用于治疗斯堪的纳维亚地区难治性儿童癫痫的有效性。
Eur J Paediatr Neurol. 2015 Jan;19(1):29-36. doi: 10.1016/j.ejpn.2014.09.005. Epub 2014 Oct 6.
6
Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes.生酮饮食起始阶段的并发症:发生率、治疗及对癫痫发作结局的影响。
Pediatr Neurol. 2017 Mar;68:35-39. doi: 10.1016/j.pediatrneurol.2017.01.007. Epub 2017 Jan 16.
7
Use of cooking oils in a 2:1 ratio classical ketogenic diet for intractable pediatric epilepsy: Long-term effectiveness and tolerability.在难治性小儿癫痫中使用经典生酮饮食(烹饪油比例为2:1):长期有效性和耐受性
Epilepsy Res. 2018 Nov;147:75-79. doi: 10.1016/j.eplepsyres.2018.09.002. Epub 2018 Sep 12.
8
Ketogenic diet therapy in infants less than two years of age for medically refractory epilepsy.生酮饮食疗法用于两岁以下药物难治性癫痫婴儿。
Seizure. 2018 Apr;57:5-7. doi: 10.1016/j.seizure.2018.02.014. Epub 2018 Mar 2.
9
Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial.经典生酮饮食与进一步抗癫痫药物治疗耐药性癫痫婴儿(KIWE):一项英国、多中心、开放标签、随机临床试验。
Lancet Neurol. 2023 Dec;22(12):1113-1124. doi: 10.1016/S1474-4422(23)00370-8.
10
The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up.中链甘油三酯生酮饮食作为难治性儿童癫痫的一种治疗选择:一项为期2年随访的前瞻性研究。
Epilepsy Behav. 2015 Oct;51:261-6. doi: 10.1016/j.yebeh.2015.07.023. Epub 2015 Aug 24.

引用本文的文献

1
Progress of ketogenic diet in the treatment of developmental epileptic encephalopathy.生酮饮食治疗发育性癫痫性脑病的研究进展
Front Pediatr. 2025 Aug 4;13:1567095. doi: 10.3389/fped.2025.1567095. eCollection 2025.
2
Efficacy and safety of a smartphone application-based treatment of ketogenic diet in pediatric refractory epilepsy.基于智能手机应用程序的生酮饮食疗法治疗小儿难治性癫痫的疗效与安全性。
Epilepsia Open. 2024 Feb;9(1):278-286. doi: 10.1002/epi4.12867. Epub 2023 Dec 21.
3
Keto-Bezoar: Adverse Event Related to Initiation of Ketogenic Diet in an Infant.
酮粪石:与婴儿开始生酮饮食相关的不良事件
JPGN Rep. 2022 Feb 25;3(2):e179. doi: 10.1097/PG9.0000000000000179. eCollection 2022 May.
4
Hospital readmissions in children with new-onset infantile epileptic spasms syndrome.儿童新发病例婴儿痉挛症的住院再入院率。
Epilepsia Open. 2023 Jun;8(2):444-455. doi: 10.1002/epi4.12711. Epub 2023 Mar 30.
5
Bibliometric analysis of global research profile on ketogenic diet therapies in neurological diseases: Beneficial diet therapies deserve more attention.对神经疾病中酮饮食疗法的全球研究概况进行文献计量分析:有益的饮食疗法值得更多关注。
Front Endocrinol (Lausanne). 2023 Jan 4;13:1066785. doi: 10.3389/fendo.2022.1066785. eCollection 2022.
6
Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.新生儿和 4 个月以下婴儿对生酮疗法的耐受性和反应。哥伦比亚麦德林一家医院中心的病例系列。
Rev Neurol. 2022 Nov 16;75(10):305-310. doi: 10.33588/rn.7510.2022134.
7
Nonketotic Hyperglycinemia: Insight into Current Therapies.非酮症高甘氨酸血症:当前治疗方法的见解
J Clin Med. 2022 May 27;11(11):3027. doi: 10.3390/jcm11113027.
8
Effects of Classic Ketogenic Diet in Children with Refractory Epilepsy: A Retrospective Cohort Study in Kingdom of Bahrain.经典生酮饮食对难治性癫痫儿童的影响:巴林王国的回顾性队列研究。
Nutrients. 2022 Apr 22;14(9):1744. doi: 10.3390/nu14091744.
9
The efficacy of non-fasting ketogenic diet protocol in the management of intractable epilepsy in pediatric patients: a single center study from Saudi Arabia.沙特阿拉伯单中心研究:非禁食生酮饮食方案治疗儿童难治性癫痫的疗效。
J Int Med Res. 2022 Mar;50(3):3000605221081714. doi: 10.1177/03000605221081714.
10
Monitoring Glucose Concentrations in Children with Epilepsy on a Ketogenic Diet.监测采用生酮饮食的癫痫患儿的血糖浓度。
Healthcare (Basel). 2022 Jan 27;10(2):245. doi: 10.3390/healthcare10020245.